Evidence map›Paper›PMID 42796013›Full record

ArticleJournal of clinical medicine2026

Real-World Effectiveness and Safety of Anifrolumab in Egyptian Patients with Moderate-to-Severe Systemic Lupus Erythematosus: A Retrospective Multicenter Study.

Samar Tharwat, Samah A El Bakry, Shereen Abdelsalam Olwan, Fatma Fayed, Enas S Zahran, Maie Helal, Mai M Morsy, Abeer Abdelmonem Shahba, Rehab Elnemr, Nehad Mohamed Elshatby and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Samar TharwatRheumatology & Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.ORCID 0000-0001-9892-2449
Samah A El BakryRheumatology Unit, Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
Shereen Abdelsalam OlwanRheumatology, Rehabilitation and Physical Medicine Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
Fatma FayedRheumatology and Immunology Unit, Internal Medicine Department, Students' Hospital, Alexandria University, Alexandria 21526, Egypt.
Enas S ZahranRheumatology and Immunology Unit, Internal Medicine Department, Faculty of Medicine, Menoufia University, Shebeen El-Kom 32511, Egypt.
Maie HelalRheumatology, Rehabilitation and Physical Medicine Department, Faculty of Medicine, Alexandria University, Alexandria 21521, Egypt.
Mai M MorsyRheumatology and Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.
Abeer Abdelmonem ShahbaRheumatology & Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
Rehab ElnemrRheumatology, Rehabilitation and Physical Medicine Department, Faculty of Medicine, Alexandria University, Alexandria 21521, Egypt.
Nehad Mohamed ElshatbyRheumatology, Rehabilitation and Physical Medicine Department, Faculty of Medicine, Alexandria University, Alexandria 21521, Egypt.
Nevine MohannadRheumatology and Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Alexandria University Hospitals, Alexandria University, Alexandria 21526, Egypt.ORCID 0000-0001-8065-0502
Gehad MaghrabyRheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo 11562, Egypt.ORCID 0000-0001-6013-2038
Kamel Heshmat GadoRheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo 11562, Egypt.
Manal TayelRheumatology and Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.
Yasmine Abu HalawaRheumatology and Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.ORCID 0009-0002-3690-0572
Dina ShahinRheumatology & Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Ahmed Yehia IsmaeelInternal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef 62511, Egypt.
Eiman SolimanRheumatology and Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.ORCID 0000-0002-9040-7626
Eman F MohamedRheumatology Unit, Internal Medicine Department, Faculty of Medicine (Girls), Al-Azhar University, Cairo 11651, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anifrolumabEgyptian patientssystemic lupus erythematosustype I interferon inhibitor

Identifiers

PMID42796013
PMCPMC13607169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.